Literature DB >> 364967

Aprindine.

P Danilo.   

Abstract

Aprindine is a long-acting antiarrhythmic agent, effective when administered orally or intravenously in the treatment of ventricular arrhythmias of varying etiologies. It may be especially useful in the treatment of the Wolff-Parkinson-White syndrome. To a lesser extent, it may be useful in the treatment of atrial arrhythmias. Side effects can be minimized by careful titration of the dose of aprindine. If the frequency of such serious side effects as cholestatic jaundice and agranulocytosis remains low enough, aprindine should prove to be a useful addition to currently available antiarrhythmic drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 364967     DOI: 10.1016/0002-8703(79)90122-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

2.  Dose-dependent pharmacokinetics of aprindine in healthy volunteers.

Authors:  T Kobari; T Itoh; T Hirakawa; H Namekawa; T Suzuki; T Satoh; N Iida; F Ohtsu; H Hayakawa
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

4.  Moxaprindine in the acute treatment of ventricular arrhythmias in patients with cardiovascular disease.

Authors:  J Staessen; H Kesteloot
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.